INO — INOVIO PHARMACEUTICALS INC

Ownership history in Headlands Technologies LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Headlands Technologies LLC reported a position in INOVIO PHARMACEUTICALS INC (INO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2025 Q3)
Avg. % of fund
0.01%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 110,068 +109,730 +32464.5% 0.02% $258K $2.34
2025 Q2 REDUCED 338 -1,022 -75.1% 0.00% $688 $2.04
2024 Q1 INITIATED 1,360 — — 0.00% $19K —
% of Fund (quarterly)    INO price (monthly, adj. close)

Other funds also holding INO

As of 2025 Q4 — sorted by position size

ADAR1 Capital Management, LLC 0.19% Green Alpha Advisors, LLC 3Y 0.11% Persistent Asset Partners Ltd 0.11% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.07% 683 Capital Management, LLC 3Y 7Y 0.02% ADAR1 Capital Management, LLC 0.01% XTX Topco Ltd 3Y 0.01% ADAGE CAPITAL PARTNERS GP, L.L.C. 3Y 7Y 0.01% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.01% Covestor Ltd 3Y 0.01%
← Back to Headlands Technologies LLC Holdings